ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma
BeiGene
Pier Luigi Zinzani; Jiří Mayer; Christopher R Flowers; Fontanet Bijou; Ana C De Oliveira; Yuqin Song; Qingyuan Zhang; Michele Merli; Krimo Bouabdallah; Peter Ganly; Huilai Zhang; Roderick Johnson; Alejandro Martín García-Sancho; Mariano Provencio Pulla; Marek Trněný; Sam Yuen; Herve Tilly; Edwin Kingsley; Gayane Tumyan; Sarit E Assouline; Rebecca Auer; Elena Ivanova; Pil Kim; Sha Huang; Richard Delarue; Judith Trotman